Avita Medical
RCEL
74 hedge funds and large institutions have $57.3M invested in Avita Medical in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 12 closing their positions.
39% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 18
16% more call options, than puts
Call options by funds: $306K | Put options by funds: $264K
2.1% more ownership
Funds ownership: 24.62% → 26.72% (+2.1%)
1% more funds holding
Funds holding: 73 → 74 (+1)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
31% less capital invested
Capital invested by funds: $82.6M → $57.3M (-$25.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.11M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.02M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$1.07M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$917K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$768K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$3.34M |
| 2 |
AIC
AWM Investment Company
New York
|
-$1.26M |
| 3 |
LCM
Legato Capital Management
San Francisco,
California
|
-$1M |
| 4 |
JP Morgan Chase
New York
|
-$375K |
| 5 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$294K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
76
AWM Investment Company
New York
| – | -$1.26M | -98,173 | Closed |
|
|
LCM
77
Legato Capital Management
San Francisco,
California
| – | -$1M | -78,268 | Closed |
|
|
CRC
78
Curi RMB Capital
Chicago,
Illinois
| – | -$294K | -23,000 | Closed |
|
|
ECM
79
ExodusPoint Capital Management
New York
| – | -$220K | -17,206 | Closed |
|
80
Citadel Advisors
Miami,
Florida
| – | -$152K | -16,319 | Closed |
|
81
SG Americas Securities
New York
| – | -$190K | -14,823 | Closed |
|
82
Lazard Asset Management
New York
| – | -$14K | -1,142 | Closed |
|
83
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$8 | -623 | Closed |
|
|
RS
84
R Squared
Central,
Hong Kong
| – | -$2.75K | -215 | Closed |
|
|
WCM
85
WealthTrak Capital Management
Virginia Beach,
Virginia
| – | -$320 | -25 | Closed |
|
86
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$102 | -8 | Closed |
|
RCEL Hedge Fund Activity: Q1 2025 in Review
74 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q1 2025, worth a combined $57.3M — down 31% from $82.6M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new RCEL positions and 12 closed out — a net gain of 1 holder — while 25 added to existing stakes and 18 trimmed.
The largest buyer was Opaleye Management, opening a new position worth an estimated $4.11M. The largest seller was Essex Investment Management, exiting entirely with an estimated $3.34M sold.
- 74 institutional investors held Avita Medical (RCEL) as of Q1 2025, up from 73 in Q4 2024.
- Funds reported $57.3M of Avita Medical stock for Q1 2025, down 31% quarter-over-quarter.
- 13 funds opened new Avita Medical positions in Q1 2025 and 12 closed out, a net change of +1 holder.
- The largest Avita Medical buyer in Q1 2025 was Opaleye Management, an estimated $4.11M added.
- The largest Avita Medical seller in Q1 2025 was Essex Investment Management, an estimated $3.34M sold.
Based on aggregated 13F filings for Q1 2025.